FDA Recall Terminated

Fresenius Naturalyte Liquid Acid Concentrate Catalog Number: 08-2301-3 Intended Use: Acid Concentrate for Bicarbonate Dialysis

Recall: Z-0887-2016 · Initiated January 18, 2016

Recall

Recall Number
Z-0887-2016
Event Number
73077
Firm
Fresenius Medical Care Renal Therapies Group, LLC
FEI Number
3001451489
Product Code
KPO
Status
Terminated
Root Cause
Error in labeling
Initiated
January 18, 2016
Posted
February 25, 2016
Terminated
August 14, 2017
Address
920 Winter St, Waltham, MA, 02451-1521

Description

Fresenius Naturalyte Liquid Acid Concentrate Catalog Number: 08-2301-3 Intended Use: Acid Concentrate for Bicarbonate Dialysis

Reason

On the label calcium (Ca) listed in the right upper corner of the label (red background) incorrectly indicates the product contains 2.5 mEq/L Ca. The concentration indicated in the list of constituents represents the actual calcium concentration of the final dialysate, 3.0 mEq/L.

Action

The firm, Fresenius Medical Care, issued an "URGENT-MEDICAL DEVICE RECALL" letter dated 1/14/2015 to its customers. The letter described the product, problem and actions to be taken. The customers were instructed to immediately examine your stock for the product; if found, discontinue use immediately; place all units in a secure, segregated area; contact your FMCNA Customer Service Team at 1-800-323-5188 for instructions how to return the affected lot (lot# 15STAC072), and promptly complete and return the attached reply form by Fax to: 781-699-9796 Attn: Quality Department or scan and email to: [email protected]. Fresenius will pick up and replace your product. If you have any additional medical concerns or questions, please contact Medical Information and Communication at 855-816-2309 or Website: www.fresenius-medinfo.com. Further information or support concerning this issue, contact the Customer Service Care Team at 800-323-5188 and reference the and Support Field Action Number.

Distribution

US Distribution to states of: KS, LA, MS, OK, and TX.

Quantity

848 (212 cases)